Lawless, Anna K. http://orcid.org/0000-0003-3811-2916
Coker, David J.
Lo, Serigne N.
Ahmed, Tasnia
Scolyer, Richard A.
Ch’ng, Sydney
Nieweg, Omgo E.
Shannon, Kerwin
Spillane, Andrew
Stretch, Jonathan R.
Thompson, John F.
Saw, Robyn P. M.
Funding for this research was provided by:
National Health and Medical Research Council (APP1093017, APP1141295)
Melanoma Research Alliance (700455)
University of Sydney
Article History
Received: 25 February 2022
Accepted: 24 May 2022
First Online: 30 June 2022
Disclosures
: R.A.S. has received fees for professional services from Evaxion, Provectus Biopharmaceuticals Australia, Qbiotics, Novartis, Merck Sharp and Dohme, NeraCare, AMGEN Inc., Bristol-Myers Squibb, Myriad Genetics, GlaxoSmithKline, F. Hoffmann-La Roche. J.F.T. has received honoraria for advisory board participation from BMS Australia, MSD Australia, GSK and Provectus Inc, travel support from GSK and Provectus Inc and support for conference attendance from Novartis. R.P.M.S. has received honoraria for advisory board participation from MSD, Qbiotics, and Novartis and speaking honoraria from BMS and Novartis. A.K.L., D.J.C., S.N.L., T.A., S.C., O.E.N., K.S., A.S., and J.R.S. have no conflicts of interest to declare.